Yi‐Hsiang Huang
Researcher Next ID · RN-014450
Researcher · Medicine
National Yang Ming Chiao Tung University
, Taiwan
- Works count
- 800
- Citation count
- 23,238
- H-index
- 63
- i10-index
- 384
Research interests
Publications
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Nature · 2021 · 10.1038/s41586-021-03362-0
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Journal of Hepatology · 2018 · 10.1016/j.jhep.2018.04.010
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2016 · 10.1016/s0140-6736(16)32453-9
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.48.5938
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Journal of Hepatology · 2009 · 10.1016/j.jhep.2009.07.009
Current projects
No projects listed.